Acquisition & Growth Consulting for Healthcare Operators in Frisco, TX
Frisco sits at the intersection of Collin and Denton counties about 28 miles north of downtown Dallas. The city has roughly tripled in population since 2010 and the demographic profile is genuinely unusual for a healthcare market — younger than the DFW average, higher household income than the DFW average, denser commercial-insurance penetration, and a meaningfully higher rate of pediatric and women's-health utilization driven by the family-formation density.
Frisco is the most distorted healthcare market in MSG's service area, and the operators who succeed here are the ones who refuse to be distorted by it. The population growth numbers are real — north of 230,000 in the city, climbing toward 250,000 in the next 18 months, with median household income running well above $130,000. The corporate relocations are real. The school-district reputation is real. What's also real, but less discussed, is that healthcare in Frisco has been chasing that growth with capital that doesn't always understand the market. The 2021-2023 era of speculative medical real estate, sponsor-backed practice rollups paying 11-13x EBITDA, and concierge platforms launching with venture-style growth assumptions left a mess that operators are still working through. The owners we meet in Frisco today are sharper, more skeptical, and more interested in advisors who will tell them what they don't want to hear. That's the engagement we run.
The inpatient and ambulatory landscape is dominated by a handful of major systems with different strategies. Baylor Scott & White Medical Center Frisco anchors one corner. Children's Health has built a massive Frisco footprint. Texas Health Frisco operates under a Texas Health Resources / UT Southwestern collaborative structure. Methodist Health System has expanded its Frisco presence aggressively over the last several years. Around those anchors, ambulatory specialty practices, ambulatory surgery centers, and specialty hospitals proliferate — Star Medical Center, Frisco Medical Center, and a long tail of single-specialty centers in dermatology, orthopedics, women's health, fertility, and pediatric subspecialty care.
The Frisco Sports Village and the broader sports-medicine economy tied to The Star, Toyota Stadium, and the Comerica Center create a specific subspecialty demand pattern that doesn't exist at this density anywhere else in MSG's service area. Sports medicine, orthopedics, physical therapy, and pediatric sports performance are real economic engines here, and practices that have built defensible positions in those service lines trade at premiums when they come to market. MSG is 320 miles south of Frisco on US-287 and I-45 — roughly four and a half to five hours of drive time. We structure Frisco engagements with a 3-day on-site immersion at kickoff, deliberate site presence at deal-cycle inflection points, and a weekly working cadence between visits.
MSG works healthcare deals as operators, not as transaction-fee chasers. Our team has built and shipped production software businesses — ServiceStorm, MFGBase, LocalAISource — and that operator depth changes how we sit at a table with healthcare ownership. We have lived through enough integrations to know what good looks like and what bad looks like, and we have the discipline to tell an owner when a deal that's attractive on paper is going to be operationally painful for two years post-close.
We charge engagement fees rather than transaction-percentage success fees. That structure removes the distortion that owners often feel from sell-side advisors whose pay depends on closing any deal at any price. It also means we will tell you to walk from a deal that doesn't serve you, and we will mean it when we say it.
And we're an out-of-DFW firm by design. Frisco owner-operators have been pitched by every Dallas-based advisory firm and most national platforms. What they often want — and rarely get — is an operator partner with no entrenched relationships in the Dallas dealmaker community, no horse in any specific platform's race, and no incentive to push them toward a particular buyer. MSG fits that profile structurally. The four-and-a-half-hour drive from Beaumont becomes part of the value proposition rather than a logistical burden.
How the work unfolds
We start a Frisco healthcare engagement with three things in week one: the financials, the patient-population analysis, and an honest conversation about why the owner is talking to us now versus six months ago or six months from now. Timing matters in this market because the deal cycle has been so volatile. Practices that were prepared to sell in 2022 walked away from offers because they expected better numbers in 2023; those numbers didn't come. Practices that pushed to sell in 2024 sometimes accepted terms they regretted because they didn't know what the next 18 months would look like. The first conversation is about whether your timing assumptions match what we're seeing in the broader market.
Financial preparation in Frisco specialty practices has a particular discipline because the patient-population data is so different from comparable-volume practices elsewhere. We build payer-by-payer waterfalls. We build a patient-attribution analysis by zip code. We build a corporate-employer concentration analysis when relevant. For sports-medicine and orthopedics practices, we build the referral-source defensibility narrative — what percentage of your volume comes from school districts, club programs, professional teams, or direct patient self-referral, and what does that mean for buyer underwriting. For women's health and fertility practices, we build the age-cohort analysis that drives long-tail patient-relationship value. For pediatric subspecialty, we build the referral-pattern analysis from the major systems.
For buy-side engagements, we build target lists against strategic logic — geographic gap-filling, service-line extension, or capacity-acquisition — and run integration playbooks tuned to Frisco realities. Staff retention in this market is hard and getting harder. The labor market for clinical and front-office staff in Collin County has tightened materially over the last three years, and integration plans that don't take staff retention seriously bleed value within the first 90 days. We build retention plans into the LOI process, not after close.
What's specific to Healthcare
Frisco healthcare is in a different cycle than most of the markets MSG works. The 2021-2023 sponsor-backed rollup era left an inventory of practices that were partially consolidated, partially integrated, and partially performing — and the next 24-36 months will see meaningful platform-level transactions as PE sponsors look to exit aggregations they assembled three to five years ago. That creates both opportunity and risk for owner-operators. Opportunity: well-positioned independent practices have leverage in a market where strategic and financial buyers are looking for clean stories to add to portfolios. Risk: the comparable-transaction data from 2021-2023 is not a reliable benchmark for what 2026 deals are actually pricing at, and owners anchored to those comps are walking away from real money.
The specialty-by-specialty consolidation cycle in Frisco is also specific. Dermatology has been heavily rolled up across DFW and Frisco specifically. Orthopedics is mid-cycle with active deal flow. Sports medicine is mid-cycle with concentration risk concerns getting more attention from buyers. Women's health and fertility are early-mid cycle with platform-building activity rather than consolidation completion. Concierge primary care has bifurcated — venture-backed platforms have struggled, while owner-operated concierge practices serving the corporate-relocation population have outperformed.
The regulatory and reimbursement landscape adds variables that out-of-state buyers underweight. Texas-specific rules around ASC ownership, scope-of-practice for advanced practice providers, and corporate-practice-of-medicine restrictions shape what deal structures are even legal. Buyers from out-of-state platforms occasionally propose structures that don't survive Texas regulatory review, and owner-operators who don't have advisors flagging those issues end up in deals that fall apart at closing. We flag those issues in week one of an engagement, not in week 20.
Twelve months into an MSG growth or acquisition engagement, a Frisco healthcare operator has clarity on what their business is actually worth in the current market, what deal structures and buyers serve them best, and what the operational path looks like through and beyond a transaction. Sell-side outcomes typically include a quality-of-earnings package that survives top-tier diligence, a defensible EBITDA bridge, a managed buyer pool with active competitive tension, and deal terms that protect the seller in earn-out, rollover, and restrictive-covenant structures. Buy-side outcomes include a target list built against strategic logic rather than what's available, integrated acquisitions with clean EHR, credentialing, and payer-contract assignments, and staff retention rates that protect the underwriting case for the deal. Across both, the operator's clarity about the next three years is materially different than at engagement start.
Things operators ask
We were quoted 11x EBITDA in 2022 and walked away. What's the realistic number now?
Specialty-dependent, but as a general frame: practice valuations in 2026 are running 2-4 turns of EBITDA below the 2021-2022 highs across most specialties. Orthopedics, gastro, dermatology, and ophthalmology have all reset materially. Owners anchored to 2022 comps are walking away from real money. The conversation we'd want to have is about what you actually need from a transaction — outright exit, partial liquidity, growth capital, succession — and what specific buyers in the current market would pay for the practice you have today. The answer is rarely the 2022 number, but it's also rarely as bad as the floor that some owners assume after hearing 'the market reset.' We'd build the actual number against actual current comparables and current buyer behavior.
Our sports medicine practice has heavy referral concentration from a few school districts and clubs. Is that a problem for valuation?
It's a structural risk that buyers will price for, but it's manageable if you tell the story right. Concentration risk in healthcare practices is always reflected in valuation — the question is how much. Two things help: first, a clear analysis of the durability of those referral relationships (how long they've existed, how they're structured, what the renewal and switching dynamics actually look like); second, a credible diversification narrative for the next 24-36 months. Practices that present concentration as a known risk with active mitigation underwrite better than practices that try to hide it or downplay it. We'd build the analysis and the narrative deliberately rather than letting buyers diligence into it cold.
We're considering rolling up two smaller specialty groups in the mid-cities and Frisco. Is the integration risk manageable?
Manageable if the integration plan is built before LOI signature, not after. The pattern that destroys value in small-group rollups is treating integration as something that happens after the deal closes. By that point you've lost the ability to negotiate retention provisions for key staff, you've already committed to an EHR strategy that may or may not be right, and you've inherited payer contract dynamics you didn't fully understand. Our integration approach builds the operational plan during diligence — credentialing-bridge timeline, EHR migration design, payer contract assignment strategy, staff retention plan, day-1 communications — so that at close you're executing a plan that's already 60% built rather than starting from scratch.
Concierge platforms keep contacting us about partnership. Are any of them real businesses?
Some are. The 2020-2022 era of venture-backed concierge platforms produced a lot of business models that haven't survived contact with healthcare operating economics. The platforms that have survived tend to share characteristics: real provider-retention track records, sustainable unit economics independent of subscription growth, real operational support that practices actually use, and capital structures that don't require unsustainable growth. Vetting them requires asking specific questions — provider turnover rates at platform practices, actual EBITDA margins of platform-aligned practices, financial commitments and exit dynamics for owner-operators who join. We've watched several of these platforms up close and can help separate the durable ones from the ones still operating on momentum.
How does MSG handle the regulatory specifics of Texas healthcare deals — corporate practice of medicine, ASC structures, etc.?
We don't replace healthcare transactional counsel — you need a Texas-specialized healthcare attorney for the legal work. What we do is flag the regulatory issues early enough that they shape deal structure rather than blowing it up at closing. Out-of-state platforms occasionally propose structures that violate Texas corporate-practice-of-medicine rules or run into ASC ownership-structure restrictions, and owners who don't have advisors flagging those issues in week one end up renegotiating fundamental deal terms in week 20. We have working relationships with several Texas healthcare law firms and coordinate closely with whichever counsel you engage.
How often will you actually be in Frisco during an engagement?
For a 12-month engagement, plan on 8-12 on-site visits. Kickoff is a 3-day immersion. Target site visits during diligence are 1-2 days each. Integration day-one and the first 30 days post-close get heavy on-site presence — usually 5-7 days across that window. Post-90 review is a 2-day visit. Weekly video cadence runs throughout. The four-and-a-half hour drive from Beaumont is a same-day round trip when something urgent breaks, and we treat that responsiveness as a structural part of the engagement rather than an exception.
Other Industries in Frisco
Growth in Other Cities
Other MSG Services
Ready to navigate your Frisco healthcare transaction with clear eyes?
Let's map your real options, build the package, and run the process the way it should run.